In Depth 14 Feb 2024 The next leap in pet health: longevity drugs for dogs Find out how we could stave off the heartbreak of saying goodbye to our dogs, as three longevity drugs for dogs could soon be approved. February 14, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2024 RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing? Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time. February 12, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Feb 2024 Biotech job market 2024: what to expect? The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year? February 9, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 8 Feb 2024 Could we see a new dawn for hair loss treatments? Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors. February 8, 2024 - 8 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
In Depth 7 Feb 2024 The biggest private biotech investments in January 2024 Jixing Pharmaceuticals, COUR Pharmaceuticals, and OnCusp Therapeutics bagged the biggest private biotech investments in January 2024. February 7, 2024 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2024 Future of cancer treatment: what will therapy look like in 2034? From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment. February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 31 Jan 2024 New epilepsy drugs: what is in the pipeline? Find out about the new epilepsy drugs currently in the pipeline, as resistance to current AEDs underscores the need for new treatments. January 31, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2024 Long COVID: are we on the verge of a breakthrough? Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities. January 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 25 Jan 2024 The trends that will shape the biotech industry in 2024 What does 2024 hold for the biotech industry? Delve into the experts’ insight on the biotech trends that will shape 2024. January 25, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jan 2024 A new chapter in cell therapy: engineered B cells reach the clinic for the first time Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field of cell therapy, having recently made it into clinical trials. But what exactly are B cells and how can they be engineered to treat diseases? […] January 24, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2024 Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases? Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases. January 19, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Jan 2024 GLP-1 agonists: what’s the hype about? GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs. January 18, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email